Terms: = Prostate cancer AND B2M, P61769, 567, ENSG00000166710
116 results:
1. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience.
Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R
Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
[TBL] [Abstract] [Full Text] [Related]
3. Caution regarding the specificities of pan-cancer microbial structure.
Gihawi A; Cooper CS; Brewer DS
Microb Genom; 2023 Aug; 9(8):. PubMed ID: 37555750
[TBL] [Abstract] [Full Text] [Related]
4. Hospitalizations Among Veterans Treated for Metastatic prostate cancer With Abiraterone or Enzalutamide.
Riekhof F; Yan Y; Bennett CL; Sanfilippo KM; Carson KR; Chang SH; Georgantopoulos P; Luo S; Govindan S; Cheranda N; Afzal A; Schoen MW
Clin Genitourin Cancer; 2024 Apr; 22(2):18-26.e3. PubMed ID: 37495480
[TBL] [Abstract] [Full Text] [Related]
5. Far from the truth: Real-world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification.
Yang X; Tan YG; Gatsinga R; Chen W; Huang HH; Loong JTK; Chua MLK; Rajasekaran T; Kanesvaran R; Tay KJ; Chen K; Yuen JSP
Int J Urol; 2023 Nov; 30(11):991-999. PubMed ID: 37431969
[TBL] [Abstract] [Full Text] [Related]
6. Plant-derived PAP proteins fused to immunoglobulin A and M Fc domains induce anti-prostate cancer immune response in mice.
Kang YJ; Kim DS; Kim S; Seo YJ; Ko K
BMB Rep; 2023 Jul; 56(7):392-397. PubMed ID: 37037672
[TBL] [Abstract] [Full Text] [Related]
7. Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical prostatectomy?
Lambert E; Allaeys C; Berquin C; De Visschere P; Verbeke S; Vanneste B; Fonteyne V; Van Praet C; Lumen N
Curr Oncol; 2023 Mar; 30(3):3447-3460. PubMed ID: 36975474
[TBL] [Abstract] [Full Text] [Related]
8. The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon.
Rakauskas A; Peters M; Ball D; Kim NH; Ahmed HU; Winkler M; Shah TT
Urol Oncol; 2023 Feb; 41(2):106.e9-106.e16. PubMed ID: 36564258
[TBL] [Abstract] [Full Text] [Related]
9. Increasing aggressive prostate cancer.
Shah N; Ioffe V; Chang JC
Can J Urol; 2022 Dec; 29(6):11384-11390. PubMed ID: 36495581
[TBL] [Abstract] [Full Text] [Related]
10. Combined MRI and PSA Strategy Improves Biopsy Decisions Compared with PSA Only: Longitudinal Observations of a Cohort of Patients with a PSA Level Less Than 20 ng/mL.
Choi MH; Ha US; Park YH; Hong SH; Lee JY; Lee YJ; Lee W; Jung S
Acad Radiol; 2023 Mar; 30(3):509-515. PubMed ID: 36127254
[TBL] [Abstract] [Full Text] [Related]
11. Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?
Morote J; Campistol M; Regis L; Celma A; de Torres I; Semidey ME; Roche S; Mast R; Santamaria A; Planas J; Trilla E
Int J Biol Markers; 2022 Jun; 37(2):218-223. PubMed ID: 35200058
[TBL] [Abstract] [Full Text] [Related]
12. Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.
Beksac AT; Ratnani P; Dovey Z; Parekh S; Falagario U; Roshandel R; Sobotka S; Kewlani D; Davis A; Weil R; Bashorun H; Jambor I; Lewis S; Haines K; Tewari AK
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1492. PubMed ID: 34931468
[TBL] [Abstract] [Full Text] [Related]
13. The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation.
Liu AY
BMC Cancer; 2021 Dec; 21(1):1335. PubMed ID: 34911496
[TBL] [Abstract] [Full Text] [Related]
14. How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
Urabe F; Kimura T; Sasaki H; Tashiro K; Iwatani K; Yasue K; Aoki M; Sato S; Takahashi H; Miki K; Egawa S
Int J Clin Oncol; 2022 Jan; 27(1):184-193. PubMed ID: 34599724
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of Several Pathways for Efficient Killing of prostate cancer Stem Cells: A Central Role of NF-κB RELA.
Witte KE; Pfitzenmaier J; Storm J; Lütkemeyer M; Wimmer C; Schulten W; Czaniera N; Geisler M; Förster C; Wilkens L; Knabbe C; Mertzlufft F; Kaltschmidt B; Am Esch JS; Kaltschmidt C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445612
[TBL] [Abstract] [Full Text] [Related]
16. Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques.
Dee EC; Muralidhar V; King MT; Martin NE; D'Amico AV; Mouw KW; Orio PF; Nguyen PL; Leeman JE
Radiother Oncol; 2021 Aug; 161():241-250. PubMed ID: 34171451
[TBL] [Abstract] [Full Text] [Related]
17. prostate cancer risk variants of the HOXB genetic locus.
Dupont WD; Breyer JP; Johnson SH; Plummer WD; Smith JR
Sci Rep; 2021 May; 11(1):11385. PubMed ID: 34059701
[TBL] [Abstract] [Full Text] [Related]
18. Time pressure predicts decisional regret in men with localized prostate cancer: data from a longitudinal multicenter study.
Hilger C; Schostak M; Otto I; Kendel F
World J Urol; 2021 Oct; 39(10):3755-3761. PubMed ID: 34021406
[TBL] [Abstract] [Full Text] [Related]
19. Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation.
Totaro A; Di Gianfrancesco L; Pinto F; Racioppi M; Palermo G; Campetella M; Santoro AA; Arbia G; Sacco E
Urologia; 2021 Aug; 88(3):194-199. PubMed ID: 33579180
[TBL] [Abstract] [Full Text] [Related]
20. Serum and Saliva Concentrations of Biochemical Parameters in Men with prostate cancer and Benign prostate Hyperplasia.
Farahani H; Alaee M; Amri J; Baghinia MR; Rafiee M
Lab Med; 2020 May; 51(3):243-251. PubMed ID: 32374392
[TBL] [Abstract] [Full Text] [Related]
[Next]
